FDA Investigator: Nadeem I. Chaudhry
- Nadeem I. Chaudhry first started conducting FDA inspections in 2008, with the last inspection in 2024. Over that time, Nadeem I. Chaudhry has conducted 186 inspections at 168 companies across 179 sites.
Get Nadeem Chaudhry's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Laurus Labs (Unit-5, Anakapalli | October 2022
Available Now - $199
Nadeem I. Chaudhry
Animal Drugs & Feeds Form 483
FDA 483 Rohto Pharmaceutical , . (Ueno Plant, Iga | Mar 2018
Available Now - $199
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Par Active Technologies Private, Alathur | Dec 2017
Available Now - $199
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Jiangsu YongAn Pharmaceutical, Huaian | July 2017
Available Now - $199
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Pharmaceutics International, Cockeysville | May 2015
Available Now - $199
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Trillium Farm Holdings, Johnstown | October 2010
Available Now - $199
Nadeem I. Chaudhry
Foods & Cosmetic Form 483
FDA 483 Viyash Life Sciences Pvt. Ltd., Visakhapatnam | 2024
Out-of-stock
Nadeem I. Chaudhry
Human Drugs Form 483
FDA 483 Admiron Life Sciences Pvt. Ltd., Paravada | 2024
Out-of-stock
Nadeem I. Chaudhry
Human Drugs Form 483
FDA 483 Shanghai Desano Chemical Pharmaceutical Co., Ltd., Pudong District | 2023
Out-of-stock
Nadeem I. Chaudhry
Human Drugs Form 483
FDA 483 Rampex Labs Private limited, Unit-2, Lankelapalem | 2022
Out-of-stock
Nadeem I. Chaudhry
Human Drugs Form 483
FDA 483 Aktinos Pharma Private Limited - Unit II, Visakhapatnam | 2022
Out-of-stock
Nadeem I. Chaudhry
Human Drugs Form 483
FDA 483 Neuland Laboratories Limited (Unit II), Isnapur | 2020
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Sun Pharmaceutical Industries Limited, Ahmednagar | 2020
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Vijayasri Organics Ltd, Parawada | 2019
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Hubei Honch Pharmaceutical Co, LTD., Huanggang | 2019
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Avra Laboratories Private Ltd., Hyderabad | 2019
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Rxhomeo Private Limited, Hyderabad | 2019
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
FDA 483 Synthokem Labs Private Limited, Sangareddy District | 2019
Out-of-stock
Nadeem I. Chaudhry
Human Drug Form 483
Co-Investigators (40)
- Colleen F. Hoyt, FDA Investigator
- Sri Rama Yellela, FDA Investigator
- Yellela, Sri Rama Kr, FDA Investigator
- Michael E. Maselli, FDA Investigator
- Samina S. Khan, FDA Investigator
- Jonathan W. Chapman, FDA Investigator
- Rebecca Rodriguez, FDA Investigator
- Toyin B. Oladimeji, FDA Investigator
- Rafael E. Arroyo, FDA Investigator
- Andrew J. Lang, FDA Investigator
- Katherine Szestypalow, FDA Investigator
- Craig P. Seaborn, FDA Investigator
- Cynthia T. Cain, FDA Investigator
- Thomas J. Prigge, FDA Investigator
- Holly J. Wilson, FDA Investigator
- Thunder N. Dunkijacobs, FDA Investigator
- Debra D. Devlieger, FDA Investigator
- Jennifer L. Jager, FDA Investigator
- Samuel A. Hamblin, FDA Investigator
- Susan M. Taylor, FDA Investigator
- Andrew I. Carr, FDA Investigator
- Michael E. Campbell, FDA Investigator
- Darren S. Morgan, FDA Investigator
- Dorathy M. Eischen, FDA Investigator
- Clinton D. Priestley, FDA Investigator
- Janet L. Bowen, FDA Investigator
- Nicholas L. Paulin, FDA Investigator
- Javonica F. Penn, FDA Investigator
- Tracey L. Harris, FDA Investigator
- Craig T. Rybus, FDA Investigator
- Steven P. Eastham, FDA Investigator
- Christian L. Witkovskie, FDA Investigator
- David L. Craft, FDA Investigator
- Christopher T. Middendorf, FDA Investigator
- Donna F. Campbell, FDA Investigator
- Rosanna M. Goodrich, FDA Investigator
- Lesley K. Satterwhite, FDA Investigator
- Anna M. Brannen, FDA Investigator
- David P. Moorhead, FDA Investigator
- Thomas C. Woods, FDA Investigator